Dr. Lucia Septién
Bioinformatics & Systems Biology
Dbv Technologies
France
Biography
Dr. Lucia Septién was appointed Chief Medical Officer in July 2016 and is a member of the Company’s Executive Committee. Dr. Septién is responsible for the Company’s clinical development programs, medical affairs, global safety and medical operations and she also has a strategic role in accelerating the development of Viaskin product candidates. Dr. Septién has more than 20 years of experience in the pharmaceutical industry. Prior to joining DBV, Septién was Vice President, Global Neurosciences at Ipsen, responsible for the Medical Strategy of the Botulinum Toxin portfolio. Prior to Ipsen, Dr. Septién served as Vice President of the Specialty Care Business Unit, Europe, at Pfizer. Prior to Pfizer, she served at Wyeth Pharma as Assistant Vice President, Global Neuroscience. Dr. Septién earned her medical degree at the National University of Mexico City, specializing in Psychiatry. She completed her post-graduate training in Nuclear Medicine at the Commisariat de l'Energie Atomique in Saclay, France.
Research Interest
Bioinformatics & Systems Biology
